Wall Street Analysts Just Trimmed Price Targets for These 5 Stocks

02. Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)

Price Reaction after the Price Target Cut: -10.70 (-17.02%)

Needham & Company LLC, on December 14, adjusted its target price for Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), a company operating in the pharmaceutical industry. The revised target has been lowered from $63.00 to $56.00, with Needham & Company LLC maintaining a “Buy” recommendation. Following this adjustment, the market responded with a significant decrease in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) stock price, resulting in a price reduction of -10.70 (-17.02%).